US Bancorp’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25K Buy
1,212
+65
+6% +$208 ﹤0.01% 3624
2025
Q4
$3.13K Hold
1,147
﹤0.01% 3664
2025
Q3
$2.49K Hold
1,147
﹤0.01% 3727
2025
Q2
$1.97K Sell
1,147
-44,648
-97% -$111K ﹤0.01% 3873
2025
Q1
$152K Buy
45,795
+33,298
+266% +$172K ﹤0.01% 2164
2024
Q4
$92.5K Sell
12,497
-7,158
-36% -$66.4K ﹤0.01% 2440
2024
Q3
$185K Sell
19,655
-8,803
-31% -$83.4K ﹤0.01% 2078
2024
Q2
$228K Sell
28,458
-3,099
-10% -$33.2K ﹤0.01% 1928
2024
Q1
$468K Buy
31,557
+16,800
+114% +$196K ﹤0.01% 1539
2023
Q4
$120K Buy
14,757
+10,170
+222% +$53.2K ﹤0.01% 2263
2023
Q3
$20.9K Sell
4,587
-910
-17% -$5.94K ﹤0.01% 2859
2023
Q2
$38.7K Sell
5,497
-94
-2% -$673 ﹤0.01% 2628
2023
Q1
$34.2K Buy
5,591
+2,354
+73% +$16.2K ﹤0.01% 2713
2022
Q4
$20.7K Buy
3,237
+730
+29% +$5.7K ﹤0.01% 2978
2022
Q3
$24K Sell
2,507
-1,492
-37% -$17.2K ﹤0.01% 2938
2022
Q2
$44K Buy
3,999
+726
+22% +$9.51K ﹤0.01% 2654
2022
Q1
$54K Sell
3,273
-1,035
-24% -$16K ﹤0.01% 2578
2021
Q4
$82K Sell
4,308
-4,181
-49% -$92K ﹤0.01% 2388
2021
Q3
$209K Buy
8,489
+2,767
+48% +$65.2K ﹤0.01% 1945
2021
Q2
$150K Buy
5,722
+1,410
+33% +$36.6K ﹤0.01% 2099
2021
Q1
$136K Sell
4,312
-16,461
-79% -$682K ﹤0.01% 2106
2020
Q4
$964K Buy
20,773
+8,025
+63% +$319K ﹤0.01% 1122
2020
Q3
$420K Buy
12,748
+9,158
+255% +$281K ﹤0.01% 1416
2020
Q2
$99K Sell
3,590
-98
-3% -$3.22K ﹤0.01% 2113
2020
Q1
$110K Buy
3,688
+1,577
+75% +$41.8K ﹤0.01% 1977
2019
Q4
$58K Buy
2,111
+886
+72% +$20.2K ﹤0.01% 2404
2019
Q3
$23K Buy
1,225
+294
+32% +$6.5K ﹤0.01% 2781
2019
Q2
$23K Buy
+931
New +$14K ﹤0.01% 2823
2016
Q1
Sell
-7,206
Closed -$55K 3595
2015
Q4
$55K Buy
7,206
+437
+6% +$3.03K ﹤0.01% 2396
2015
Q3
$39K Buy
+6,769
New +$52.7K ﹤0.01% 2579
2015
Q2
Sell
-7,920
Closed -$96K 3597
2015
Q1
$96K Buy
+7,920
New +$89.2K ﹤0.01% 2180

Other funds holding IOVA